Same Indication

Pembrolizumab vs Trimethoprim

Pembrolizumab vs Trimethoprim: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Trimethoprim.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Trimethoprim: Dihydrofolate reductase inhibitor (bacterial selective).

Pharmacokinetics

Half-life: Pembrolizumab — 26 days; Trimethoprim — 8-10 hours.

Chemical Properties

Molecular Formula: Trimethoprim — C14H18N4O3.

Molecular Weight: Trimethoprim — 290.3180 g/mol.

Type: Pembrolizumab — Antibody; Trimethoprim — Small molecule.